Humacyte
HUMA
123 hedge funds and large institutions have $150M invested in Humacyte in 2024 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 17 closing their positions.
264% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 14
171% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 17
107% more capital invested
Capital invested by funds: $72.4M → $150M (+$77.4M)
28% more funds holding
Funds holding: 96 → 123 (+27)
6.3% more ownership
Funds ownership: 19.91% → 26.2% (+6.3%)
8% less call options, than puts
Call options by funds: $3.34M | Put options by funds: $3.61M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$8.62M |
| 3 |
Millennium Management
New York
|
+$6.95M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$6.05M |
| 5 |
Two Sigma Investments
New York
|
+$5.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$6.71M |
| 2 |
SCM
Sio Capital Management
New York
|
-$6.22M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.75M |
| 4 |
PGP
Prescott General Partners
Boca Raton,
Florida
|
-$1.77M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.09M |
HUMA Hedge Fund Activity: Q2 2024 in Review
123 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q2 2024, worth a combined $150M — up 107% from $72.4M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new HUMA positions and 17 closed out — a net gain of 29 holders — while 51 added to existing stakes and 14 trimmed.
The largest buyer was BlackRock, adding an estimated $12.2M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $6.71M sold.
- 123 institutional investors held Humacyte (HUMA) as of Q2 2024, up from 96 in Q1 2024.
- Funds reported $150M of Humacyte stock for Q2 2024, up 107% quarter-over-quarter.
- 46 funds opened new Humacyte positions in Q2 2024 and 17 closed out, a net change of +29 holders.
- The largest Humacyte buyer in Q2 2024 was BlackRock, an estimated $12.2M added.
- The largest Humacyte seller in Q2 2024 was AIGH Capital Management, an estimated $6.71M sold.
Based on aggregated 13F filings for Q2 2024.